Cargando…
A novel nitidine chloride nanoparticle overcomes the stemness of CD133(+)EPCAM(+) Huh7 hepatocellular carcinoma cells for liver cancer therapy
BACKGROUND: Stemness of CD133(+)EPCAM(+) hepatocellular carcinoma cells ensures cancer resistance to apoptosis,which is a challenge to current liver cancer treatments. In this study, we evaluated the tumorcidal activity of a novel nanoparticle of nitidine chloride (TPGS-FA/NC, TPGS-FA: folic acid mo...
Autores principales: | Li, Danni, Zhang, Qiying, Zhou, Yuzhu, Zhu, Hua, Li, Tong, Du, Fangkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277916/ https://www.ncbi.nlm.nih.gov/pubmed/35820920 http://dx.doi.org/10.1186/s40360-022-00589-z |
Ejemplares similares
-
Insights into an NEk2 inhibitory profile of nitidine chloride by molecular docking and biological evaluation
por: Li, Danni, et al.
Publicado: (2022) -
Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma
por: Li, Danni, et al.
Publicado: (2021) -
CD133(+)EpCAM(+) Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells
por: Chen, Yi, et al.
Publicado: (2012) -
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
por: Karabicici, Mustafa, et al.
Publicado: (2021) -
A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM(−)/CD133(−) nonStem Cells into EpCAM(+)/CD133(+) Liver Cancer Stem Cells in HCC Cell Line HuH7
por: Firtina Karagonlar, Zeynep, et al.
Publicado: (2020)